Taking Your Fitness Routine to the Next Level
Recorded on June 23rd, 2022 as part of the African American Myeloma Chapter in the Myeloma Crowd Community by HealthTree Program with Vania Hudson.
The Myeloma Crowd brings information from the experts to the patients! Learn more at https://www.myelomacrowd.org/
HealthTree Cure Hub helps you find your best treatment options and accelerate a cure for multiple myeloma. Join today at https://www.healthtree.org/
Follow Myeloma Crowd:
Twitter: www.twitter.com/myelomacrowd
Facebook: www.facebook.com/myelomacrowd
Instagram: www.instagram.com/myelomacrowd
Видео Taking Your Fitness Routine to the Next Level канала HealthTree Foundation for Multiple Myeloma
The Myeloma Crowd brings information from the experts to the patients! Learn more at https://www.myelomacrowd.org/
HealthTree Cure Hub helps you find your best treatment options and accelerate a cure for multiple myeloma. Join today at https://www.healthtree.org/
Follow Myeloma Crowd:
Twitter: www.twitter.com/myelomacrowd
Facebook: www.facebook.com/myelomacrowd
Instagram: www.instagram.com/myelomacrowd
Видео Taking Your Fitness Routine to the Next Level канала HealthTree Foundation for Multiple Myeloma
Показать
Комментарии отсутствуют
Информация о видео
27 июня 2022 г. 12:01:59
01:06:07
Другие видео канала
![Round Table Audience Q&A Two | RT Irvine, CA Nov 5, 2022](https://i.ytimg.com/vi/J1B5MuU1_t0/default.jpg)
![CELMoDs® Mezigdomide | Paul Richardson, MD | IMS 2022](https://i.ytimg.com/vi/i_hn7jiwJjo/default.jpg)
![The HealthTree Foundation 10 Year Anniversary](https://i.ytimg.com/vi/yFw06QnBIls/default.jpg)
![Medicare 101 for Myeloma Patients: What You Need to Know for 2023](https://i.ytimg.com/vi/f1KQPIOBRo4/default.jpg)
![Mezigdomide, Tazemetostat, and Dex in RRMM: Results from CA057-003 | Luciano Costa, MD | EHA 2024](https://i.ytimg.com/vi/9th9Zueob7U/default.jpg)
![Exciting Advances in Myeloma Treatment | Timothy Schmidt, MD | ASCO 2023](https://i.ytimg.com/vi/eSyF8IXp77U/default.jpg)
![ImmunoPET- an Advanced Companion to MRD Testing](https://i.ytimg.com/vi/1ut5abb27Oo/default.jpg)
![Health Disparities Related to CAR-T Therapy in Myeloma | Samer Al Hadidi, MD | ASH 2021](https://i.ytimg.com/vi/TLaY3cRCXnA/default.jpg)
![First-line Vs. Second-Line Treatment | Matthew LeBlanc, PhD | IMS 2022](https://i.ytimg.com/vi/7PnS63MpePY/default.jpg)
![MASTER Trial Update: MRD based response adaptive therapy | Luciano Costa, MD, PhD | ASH 2021](https://i.ytimg.com/vi/XwuMkv8LqU8/default.jpg)
![Quad Therapies and Side Effects | Nathan Sweeney, PhD | ASH 2022](https://i.ytimg.com/vi/JTqQCn2FHiI/default.jpg)
![iSTOPMM study and early MGUS and SMM screening | Joshua Richter, MD | ASH 2021](https://i.ytimg.com/vi/mUA_n84ERWI/default.jpg)
![MCRT San Diego 2020: Myeloma Expert Panel – Q&A Afternoon Session](https://i.ytimg.com/vi/WXPE2lEypnY/default.jpg)
![Benjamin Derman, MD | MCRT Chicago, Illinois April 30, 2022](https://i.ytimg.com/vi/quT0Z9miSag/default.jpg)
![Vaccinations & iStopMM Trial | Natalie Callander, MD | IMS 2022](https://i.ytimg.com/vi/ZEawHiMA-jI/default.jpg)
![IMS Updates | Saad Usmani, MD, FACP | IMS 2022](https://i.ytimg.com/vi/ZjPbuu0PAfc/default.jpg)
![Ide-cel Without Front-Line ASCT: KARMMA-2 Cohort 2B | Xavier Leleu, MD, MSc, PhD, EHA 2024](https://i.ytimg.com/vi/QSWK9pGJlj0/default.jpg)
![Hope for the Future in Black Myeloma- A Black Myeloma Health Panel](https://i.ytimg.com/vi/tA9XRQ7iYKI/default.jpg)
![Bike The Coast Day 6](https://i.ytimg.com/vi/6lnGTlVAUTs/default.jpg)
![Why Stem Cells Matter - William Matsui, MD | RT Austin, TX Mar 25, 2023](https://i.ytimg.com/vi/glzB7-PUHPU/default.jpg)
![Benefit Study IsaRVd vs IsaRd NDMM TI | Xavier Leleu, MD, MSc, PhD | EHA 2024](https://i.ytimg.com/vi/UvIDQ4SMoyA/default.jpg)